Elmwood Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26
Closed -$2K 139
2021
Q4
$2K Buy
+26
New +$2.03K ﹤0.01% 341
2021
Q2
$2K Hold
26
﹤0.01% 301
2021
Q1
$2K Buy
+26
New +$2.04K ﹤0.01% 292
2020
Q3
$2K Hold
32
﹤0.01% 232
2020
Q2
$2K Sell
32
-107
-77% -$7.6K ﹤0.01% 232
2020
Q1
$9.96K Buy
+139
New +$9.8K 0.01% 192
2019
Q4
Sell
-143
Closed -$11K 111
2019
Q3
$11K Buy
143
+1
+0.7% +$73 0.01% 175
2019
Q2
$10K Buy
142
+1
+0.7% +$71 0.01% 192
2019
Q1
$10K Hold
141
0.01% 189
2018
Q4
$8K Buy
141
+1
+0.7% +$63 0.01% 202
2018
Q3
$9.4K Buy
140
+1
+0.7% +$67 0.01% 204
2018
Q2
$9.05K Hold
139
0.01% 203
2018
Q1
$9.96K Buy
+139
New +$10K 0.01% 192

Other funds holding CL

Elmwood Wealth Management's CL Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 26 shares — an estimated $2K sold.

Elmwood Wealth Management first reported a position in CL in Q1 2018 and held it in 13 quarters. The position peaked at $11K in Q3 2019. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • Elmwood Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • Elmwood Wealth Management sold 26 Colgate-Palmolive shares in Q1 2022, an estimated $2K.
  • Elmwood Wealth Management first reported a position in Colgate-Palmolive in Q1 2018 and held it in 13 quarters.
  • Elmwood Wealth Management's Colgate-Palmolive position peaked at $11K in Q3 2019.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.